A new quantitative reverse transcription PCR assay to improve the routine diagnosis of paracoccidioidomycosis
Medical Mycology · 2024
DOI: 10.1093/mmy/myae125 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Medical Mycology, 2024. Verfasst von Priscila Marques de Macedo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Pesquisa Clínica em Dermatologia Infecciosa, Instituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz),…. Hauptthemen laut MEDLINE: Paracoccidioidomycosis, Paracoccidioides, Real-Time Polymerase Chain Reaction, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Paracoccidioides are dimorphic fungal pathogens and the etiological agents of paracoccidioidomycosis (PCM). This severe systemic mycosis is restricted to Latin America, where it has been historically endemic. Currently, PCM presents the fewest diagnostic tools available when compared to other endemic mycoses. The main PCM diagnostic methods also have limitations. Molecular methods using different protocols have been proposed, but are restricted to a few regions. An analytical transversal study was conducted to evaluate a new molecular tool using specimens from patients diagnosed with PCM at a reference center for endemic mycoses in Rio de Janeiro, Brazil. After whole nucleic acid (WNA) extraction, RT-qPCR was performed in two independent simplex reactions, targeting the mitochondrial small subunit ribosomal RNA genes of Paracoccidioides brasiliensis and Paracoccidioides lutzii. Additionally, WNAs from all PCM-related Paracoccidioides species and from 114 other fungal strains, as well as from samples obtained from patients diagnosed with other endemic mycoses and tuberculosis, were also tested for specificity. The RT-qPCR targeting P. brasiliensis successfully amplified genetic material from all tested Paracoccidioides species but not P. lutzii, which is why a specific RT-qPCR was designed. The RT-qPCR efficiency was 1.95 (95%) with 100% analytical specificity for both targets. All included PCM clinical samples were positive (100% sensitivity) for P. brasiliensis, and all yielded negative for P. lutzii. Additionally, all samples collected from patients with other diseases were negative, reinforcing the assay’s specificity. In conclusion, this study proposes a new accurate tool to cover gaps, contributing to the molecular diagnosis of this neglected disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Pesquisa Clínica em Dermatologia Infecciosa, Instituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
- Mycology Department, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Institut Pasteur, Université Paris Cité, Paris, France.
- Laboratoire de Parasitologie-Mycologie, AP-HP, Hôpital Saint-Louis, Paris, France.
- Departamento de Microbiologia, Imunologia e Parasitologia, Laboratório de Patógenos Fúngicos Emergentes, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
- Laboratório de Micologia, Instituto Nacional de Infectologia Evandro Chagas (INI), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
ORCID-Profile: Priscila Marques de Macedo, Rodrigo Almeida-Paes, Alexandre Alanio
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Agence Nationale de la Recherche
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Marques de Macedo, P., Sturny-Leclère, A., Hamane, S., Pautet, T., Rodrigues, A. M., Freitas, D. F. S., Valle, A. C. F. D., Zancopé-Oliveira, R. M., Almeida-Paes, R., & Alanio, A. (2024). A new quantitative reverse transcription PCR assay to improve the routine diagnosis of paracoccidioidomycosis. Medical Mycology. https://doi.org/10.1093/mmy/myae125
Vancouver
Marques de Macedo P, Sturny-Leclère A, Hamane S, Pautet T, Rodrigues AM, Freitas DFS, et al. A new quantitative reverse transcription PCR assay to improve the routine diagnosis of paracoccidioidomycosis. Medical Mycology. 2024. doi:10.1093/mmy/myae125
BibTeX
@article{MarquesdeMacedo2024,
author = {Marques de Macedo, Priscila and Sturny-Leclère, Aude and Hamane, Samia and Pautet, Thierry and Rodrigues, Anderson Messias and Freitas, Dayvison Francis Saraiva and Valle, Antonio Carlos Francesconi do and Zancopé-Oliveira, Rosely Maria and Almeida-Paes, Rodrigo and Alanio, Alexandre},
title = {A new quantitative reverse transcription PCR assay to improve the routine diagnosis of paracoccidioidomycosis},
journal = {Medical Mycology},
year = {2024},
doi = {10.1093/mmy/myae125}
}
EUVIMED